TTOO Current Ratio from 2010 to 2024
| TTOO Stock | USD 2.76 0.04 1.47% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 0.4468051 | Current Value 0.42 | Quarterly Volatility 4.02035509 |
Check T2 Biosystms financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TTOO main balance sheet or income statement drivers, such as Depreciation And Amortization of 843.9 K, Interest Expense of 4.9 M or Total Revenue of 9.8 M, as well as many exotic indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0 or Days Sales Outstanding of 131. TTOO financial statements analysis is a perfect complement when working with T2 Biosystms Valuation or Volatility modules.
TTOO | Current Ratio |
Latest T2 Biosystms' Current Ratio Growth Pattern
Below is the plot of the Current Ratio of T2 Biosystms over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. T2 Biosystms' Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in T2 Biosystms' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.87 X | 10 Years Trend |
|
Current Ratio |
| Timeline |
TTOO Current Ratio Regression Statistics
| Arithmetic Mean | 4.33 | |
| Geometric Mean | 2.53 | |
| Coefficient Of Variation | 92.90 | |
| Mean Deviation | 2.87 | |
| Median | 4.63 | |
| Standard Deviation | 4.02 | |
| Sample Variance | 16.16 | |
| Range | 15.1894 | |
| R-Value | (0.52) | |
| Mean Square Error | 12.65 | |
| R-Squared | 0.27 | |
| Significance | 0.05 | |
| Slope | (0.47) | |
| Total Sum of Squares | 226.29 |
TTOO Current Ratio History
About T2 Biosystms Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include T2 Biosystms income statement, its balance sheet, and the statement of cash flows. T2 Biosystms investors use historical funamental indicators, such as T2 Biosystms's Current Ratio, to determine how well the company is positioned to perform in the future. Although T2 Biosystms investors may use each financial statement separately, they are all related. The changes in T2 Biosystms's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on T2 Biosystms's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on T2 Biosystms Financial Statements. Understanding these patterns can help to make the right decision on long term investment in T2 Biosystms. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 0.45 | 0.42 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards T2 Biosystms in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, T2 Biosystms' short interest history, or implied volatility extrapolated from T2 Biosystms options trading.
Currently Active Assets on Macroaxis
When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:Check out the analysis of T2 Biosystms Correlation against competitors. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for TTOO Stock analysis
When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.19) | Revenue Per Share 2.756 | Quarterly Revenue Growth (0.69) | Return On Assets (0.85) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.